$MCVT
Mill City Ventures III, Ltd Stock $mcvt

$mcvt Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000165495423010870 Filed on August 15, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$303.8K	$337.5K
YoY Change	-570.49%	-54.04%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$421.4K	$530.0K
YoY Change	-62.81%	16.62%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$421.4K	$570.0K
YoY Change	-64.28%	13.5%
Operating Profit
YoY Change
Interest Expense	$0.00	$43.33K
YoY Change	-100.0%	-9.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$306.0K	$360.0K
YoY Change	-573.84%	-50.97%
Income Tax	-$63.60K	$287.0K
% Of Pretax Income	-20.79%	79.72%
Net Earnings	$369.6K	$70.00K
YoY Change	-1122.86%	-86.49%
Net Earnings / Revenue	121.65%	20.74%
Basic Earnings Per Share	$0.06	$0.01
Diluted Earnings Per Share	$0.06	$0.01
COMMON SHARES
Basic Shares Outstanding	6.185M shares	6.185M shares
Diluted Shares Outstanding	6.358M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$962.9K	$1.100M
YoY Change	-48.28%	74.72%
Cash & Equivalents	$962.9K	$1.102M
Short-Term Investments
Other Short-Term Assets	$217.4K	$160.0K
YoY Change	86.93%	19.75%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.649M	$1.820M
YoY Change	-47.92%	25.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.72K	$10.00K
YoY Change	-31.73%	-62.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.259M	$1.290M
YoY Change	742.9%	763.92%
Other Assets	$397.0K	$430.0K
YoY Change	9825.0%
Total Long-Term Assets	$17.97M	$16.96M
YoY Change	-0.67%	10.37%
TOTAL ASSETS
Total Short-Term Assets	$1.649M	$1.820M
Total Long-Term Assets	$17.97M	$16.96M
Total Assets	$19.62M	$18.78M
YoY Change	-7.71%	11.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$124.1K	$80.00K
YoY Change	-7.4%	54.49%
Accrued Expenses	$14.72K	$10.00K
YoY Change	-90.22%	-95.62%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$138.8K	$90.00K
YoY Change	-51.21%	-67.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$0.00	$10.00K
YoY Change
Total Long-Term Liabilities	$0.00	$10.00K
YoY Change	-100.0%	-99.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$138.8K	$90.00K
Total Long-Term Liabilities	$0.00	$10.00K
Total Liabilities	$138.8K	$97.13K
YoY Change	-94.66%	-95.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.160M	-$1.160M
YoY Change	0.0%	0.0%
Common Stock	$1.473M	$1.472M
YoY Change	11955.87%	13464.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.48M	$18.68M
YoY Change
Total Liabilities & Shareholders Equity	$19.62M	$18.78M
YoY Change	-7.71%	11.66%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$369.6K	$70.00K
YoY Change	-1122.86%	-86.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$560.8K	$3.410M
YoY Change	-81.6%	-10.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	424.0K	-2.750M
YoY Change	-90.09%	-15.38%
NET CHANGE
Cash From Operating Activities	-560.8K	3.410M
Cash From Investing Activities
Cash From Financing Activities	424.0K	-2.750M
Net Change In Cash	-136.8K	660.0K
YoY Change	-111.1%	18.16%
FREE CASH FLOW
Cash From Operating Activities	-$560.8K	$3.410M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Notes Receivable Net NotesReceivableNet	250000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5483	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	428000	usd
CY2023Q2	us-gaap	Assets Assets	18781573	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	2236711	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	197591	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001425355
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	111111111	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185255	shares
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045	pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41472
	dei	Entity Registrant Name EntityRegistrantName	MILL CITY VENTURES III, LTD.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0316651
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1907 Wayzata Blvd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#205
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wayzata
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55391
	dei	City Area Code CityAreaCode	952
	dei	Local Phone Number LocalPhoneNumber	479-1923
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6185255	shares
CY2023Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16528425	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1101527	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	250000	usd
CY2023Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	158839	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	218440	usd
CY2023Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	309299	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	250879	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16398	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	201000	usd
CY2022Q4	us-gaap	Assets Assets	18734790	usd
CY2023Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	77311	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	776514	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5537	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	16562	usd
CY2023Q2	us-gaap	Deferred Income DeferredIncome	14279	usd
CY2022Q4	us-gaap	Deferred Income DeferredIncome	70154	usd
CY2023Q2	us-gaap	Liabilities Liabilities	97127	usd
CY2022Q4	us-gaap	Liabilities Liabilities	863230	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	12215	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12215	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15043291	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15043291	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1460209	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2023Q2	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Investment Loss AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss	-1802749	usd
CY2022Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Investment Loss AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss	-1086739	usd
CY2023Q2	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions	5155200	usd
CY2022Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions	5713829	usd
CY2023Q2	mcvt	Stockholders Equity Unrealized Appreciation In Value Of Investments StockholdersEquityUnrealizedAppreciationInValueOfInvestments	-24055	usd
CY2022Q4	mcvt	Stockholders Equity Unrealized Appreciation In Value Of Investments StockholdersEquityUnrealizedAppreciationInValueOfInvestments	-651371	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18684446	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18781573	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18734790	usd
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.02
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.89
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	907502	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1236505	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1771530	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2236711	usd
CY2023Q2	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	907502	usd
CY2022Q2	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	1236505	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	1771530	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	287325	usd
	us-gaap	Professional Fees ProfessionalFees	417176	usd
	us-gaap	Professional Fees ProfessionalFees	392989	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	147161	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	114542	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1277600	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	310984	usd
CY2023Q2	us-gaap	General Insurance Expense GeneralInsuranceExpense	26522	usd
CY2022Q2	us-gaap	General Insurance Expense GeneralInsuranceExpense	26979	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	53522	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	57076	usd
CY2023Q2	us-gaap	Occupancy Net OccupancyNet	21072	usd
CY2022Q2	us-gaap	Occupancy Net OccupancyNet	19141	usd
	us-gaap	Occupancy Net OccupancyNet	40115	usd
	us-gaap	Occupancy Net OccupancyNet	35953	usd
CY2023Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	30000	usd
CY2022Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	87073	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	562968	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	117073	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	43333	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	47794	usd
	us-gaap	Interest Expense InterestExpense	78000	usd
	us-gaap	Interest Expense InterestExpense	117853	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	14632	usd
CY2022Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	9135	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	32481	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	16145	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	570045	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	502255	usd
	us-gaap	Operating Expenses OperatingExpenses	2461862	usd
	us-gaap	Operating Expenses OperatingExpenses	1048073	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	337457	usd
CY2022Q2	us-gaap	Net Investment Income NetInvestmentIncome	734250	usd
	us-gaap	Net Investment Income NetInvestmentIncome	-690332	usd
	us-gaap	Net Investment Income NetInvestmentIncome	1188638	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	41371	usd
CY2022Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-5750	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-558629	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	133020	usd
CY2023Q2	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-21107	usd
CY2022Q2	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	5750	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	627316	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-16297	usd
CY2023Q2	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	20264	usd
CY2022Q2	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	0	usd
	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	68687	usd
	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	116723	usd
CY2023Q2	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	357721	usd
CY2022Q2	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	734250	usd
	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	-621645	usd
	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	1305361	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	287000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	216242	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25678	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	375242	usd
CY2023Q2	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	70721	usd
CY2022Q2	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	518008	usd
	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	-647323	usd
	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	930119	usd
CY2023Q2	mcvt	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	0.01
CY2022Q2	mcvt	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	0.11
	mcvt	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.10
	mcvt	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	0.19
CY2023Q2	mcvt	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	6185255	shares
CY2022Q2	mcvt	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	4821136	shares
	mcvt	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	6185255	shares
	mcvt	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	4808508	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	18613725	usd
CY2023Q2	mcvt	Distribution Of Dividend DistributionOfDividend	0	usd
CY2023Q2	mcvt	Stock Options Issued StockOptionsIssued	0	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	50457	usd
CY2023Q2	mcvt	Undistributed Net Realized Gain On Investment Transactions UndistributedNetRealizedGainOnInvestmentTransactions	41371	usd
CY2023Q2	mcvt	Depreciation In Value Of Investments DepreciationInValueOfInvestments	-21107	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18684446	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	13826160	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	82439	usd
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	518008	usd
CY2022Q2	mcvt	Undistributed Net Realized Loss On Investment Transactions UndistributedNetRealizedLossOnInvestmentTransactions	-5750	usd
CY2022Q2	mcvt	Appreciation In Value Of Investments AppreciationInValueOfInvestments	5750	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	14426607	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
	mcvt	Stock Options Issued StockOptionsIssued	1460209	usd
	mcvt	Net Investment Loss Net Of Tax Benefit NetInvestmentLossNetOfTaxBenefit	-716010	usd
	mcvt	Undistributed Net Realized Loss On Investment Transactions UndistributedNetRealizedLossOnInvestmentTransactions	-558629	usd
	mcvt	Appreciation In Value Of Investments AppreciationInValueOfInvestments	627316	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18684446	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13414049	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	82439	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	813396	usd
	mcvt	Undistributed Net Realized Gain On Investment Transactions UndistributedNetRealizedGainOnInvestmentTransactions	133020	usd
	mcvt	Depreciation In Value Of Investments DepreciationInValueOfInvestments	-16297	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	14426607	usd
	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	-647323	usd
	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	930119	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	627316	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-16297	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-558629	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	133020	usd
	mcvt	Purchases Of Investments PurchasesOfInvestments	8900500	usd
	mcvt	Purchases Of Investments PurchasesOfInvestments	9103580	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9149194	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	7977898	usd
	mcvt	Issuance Of Stock Options IssuanceOfStockOptions	1460209	usd
	mcvt	Issuance Of Stock Options IssuanceOfStockOptions	0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-227000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1073758	usd
	mcvt	Common Shares Issued For Expense Payment CommonSharesIssuedForExpensePayment	0	usd
	mcvt	Common Shares Issued For Expense Payment CommonSharesIssuedForExpensePayment	82439	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-70516	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	39772	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	58420	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	115072	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1900000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-710228	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-23127	usd
	mcvt	Increase Decrease In Deferred Interest Income IncreaseDecreaseInDeferredInterestIncome	55875	usd
	mcvt	Increase Decrease In Deferred Interest Income IncreaseDecreaseInDeferredInterestIncome	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11886	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3381576	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2750000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	6075000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	2750000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	4000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2075000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11886	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1306576	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1936148	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1101527	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	629572	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	mcvt	Fair Value Warrants FairValueWarrants	0	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	870000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.11
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	870000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.11
CY2022Q2	mcvt	Investment Company Net Increase Decrease In Net Assets From Operations InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations	2022	usd
CY2023Q2	mcvt	Investment Company Net Increase Decrease In Net Assets From Operations InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations	70721	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6185255	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4821136	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
	mcvt	Investment Company Net Increase Decrease In Net Assets From Operations InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations	647323	usd
	mcvt	Investment Company Net Increase Decrease In Net Assets From Operations InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations	930119	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6185255	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4808508	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.02
CY2023Q2	mcvt	Market Value Of Investments Per Share MarketValueOfInvestmentsPerShare	2.67
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185255	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6185255	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4808508	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4794744	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4877654	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4918845	shares
CY2023Q2	mcvt	Net Assets At End Of Period NetAssetsAtEndOfPeriod	18684446	usd
	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	-0.0603	pure
	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	0.0194	pure
	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	0.6192	pure
	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	0.0406	pure
	mcvt	Investment Company Realized Gains Losses Ratio InvestmentCompanyRealizedGainsLossesRatio	0.5736	pure

Files In Submission

Name	View Source	Status
0001654954-23-010870-index-headers.html	Edgar Link	pending
0001654954-23-010870-index.html	Edgar Link	pending
0001654954-23-010870.txt	Edgar Link	pending
0001654954-23-010870-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mcvt-20230630.xsd	Edgar Link	pending
mcvt_10q.htm	Edgar Link	pending
mcvt_ex101.htm	Edgar Link	pending
mcvt_ex311.htm	Edgar Link	pending
mcvt_ex312.htm	Edgar Link	pending
mcvt_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
mcvt-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mcvt-20230630_def.xml	Edgar Link	unprocessable
mcvt-20230630_lab.xml	Edgar Link	unprocessable
mcvt_10q_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mcvt-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MCVT
Mill City Ventures III, Ltd Stock $mcvt

2023 Q3 Form 10-Q Financial Statement

#000165495423010870 Filed on August 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT Mill City Ventures III, Ltd Stock $mcvt

2023 Q3 Form 10-Q Financial Statement

#000165495423010870 Filed on August 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT
Mill City Ventures III, Ltd Stock $mcvt